This invention relates to novel 9-aza-bicyclo[3.3.1]nonane derivatives
useful as monoamine neurotransmitter re-uptake inhibitors.In other
aspects the invention relates to the use of these compounds in a method
for therapy and to pharmaceutical compositions comprising the compounds
of the invention.